Acrivon Therapeutics Inc.... (ACRV)
5.59
0.03 (0.54%)
At close: Jan 15, 2025, 2:10 PM
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 |
| Net Income | -60.39M | -31.17M | -16.24M | -5.31M |
| Depreciation & Amortization | 536.00K | 364.00K | 37.00K | 13.00K |
| Stock-Based Compensation | 11.62M | 2.19M | 497.00K | 3.00K |
| Other Working Capital | 4.53M | -1.29M | -470.00K | 236.00K |
| Other Non-Cash Items | 1.06M | 33.00K | 1.14M | 2.10M |
| Deferred Income Tax | -3.61M | n/a | 255.00K | 71.00K |
| Change in Working Capital | 8.14M | -1.53M | 328.00K | 317.00K |
| Operating Cash Flow | -42.64M | -30.12M | -13.98M | -2.80M |
| Capital Expenditures | -1.29M | -2.17M | -238.00K | -15.00K |
| Acquisitions | n/a | n/a | n/a | n/a |
| Purchase of Investments | -56.53M | -150.18M | n/a | n/a |
| Sales Maturities Of Investments | 108.53M | 10.67M | n/a | n/a |
| Other Investing Acitivies | n/a | n/a | n/a | n/a |
| Investing Cash Flow | 50.72M | -141.68M | -238.00K | -15.00K |
| Debt Repayment | n/a | n/a | n/a | 58.00K |
| Common Stock Repurchased | n/a | n/a | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | -1.55M | -2.75M | 112.22M | 2.83M |
| Financial Cash Flow | -1.55M | 101.71M | 112.22M | 2.89M |
| Net Cash Flow | 6.52M | -70.08M | 98.00M | 71.00K |
| Free Cash Flow | -43.93M | -32.28M | -14.22M | -2.82M |